As of Friday, the Biden Administration has secured a supply of a recently authorized COVID-19 therapeutic treatment, with the U.S. Department of Health and Human Services and the Department of Defense collaborating to purchase 100,000 courses of a second treatment from Eli Lilly and Company.
Biden Administration secures supply of new COVID-19 therapeutic treatment
